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1. Introduction  
Exposure to environmental aerosols of submicrometer size may cause significant risks to 
human health. Submicrometer aerosols include particles in the ultrafine (<100 nm) and fine 
(100 nm to 1 μm) regimes. Recent studies indicate that aerosols in this size range are 
biologically more active and potentially more toxic than micrometer particles of the same 
material (Kreyling et al., 2006; Kreyling et al., 2004; Li et al., 2003; Oberdorster and Utell 
2002). Sources of submicrometer aerosols include diesel exhaust (50 to 500 nm) (Kittelson 
1998), cigarette smoke (140 to 500 nm) (Bernstein 2004; Keith 1982), and radioactive decay (1 
to 200 nm) (ICRP 1994). Submicrometer bioaerosols include respiratory specific viruses such 
as Avian flu and SARS, which typically range from 20 to 200 nm (Mandell et al., 2004). These 
aerosols may deposit in the respiratory airways in discrete amounts resulting in local injury 
and spread of infectious diseases. Considering the extrathoracic nasal airways, which 
include the nasal passages, pharynx, and larynx, the deposition of submicrometer aerosols is 
associated with a number of detrimental health effects. The deposition of cigarette smoke 
particles has been quantitatively linked to the formation of respiratory tract tumors at 
specific sites (Martonen 1986). Yang et al. (1989) reported that respiratory tract cancers per 
unit surface area are approximately 3,000 times more likely in the extrathoracic airways 
including the larynx. Ostiguy et al. (2008) summarized the adverse health effects due to 
various nanoparticles such as carbon nanotubes, fullerenes, inorganic and organic 
nanoparticles, and quantum dots. Gurr et al. (2005) studied the effect of ultrafine TiO2 
particles on human bronchial epithelial cells and reported that TiO2 particles of 10 and 20 
nm triggered oxidative DNA damage and lipid peroxidation, the later of which may also 
explains the cytotoxicity of water-soluble fullerenes or nC60 (Sayes et al., 2005).  
Compared to adults, infants and children are more susceptible to respiratory risks. Exposure 
to ambient toxicants in children may cause adverse effects such as nasal obstruction, 
sinusitis, nasal carcinomas, and spread of infectious diseases. Respiratory disease remains a 
leading cause of childhood morbidity in the U.S. and other developed countries and is a 
leading cause to childhood deaths worldwide (U.S. Surgeon General Report 2007). 
Epidemiological studies have shown that children are biologically more susceptible to 
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particulate matters (PM) than adults due to their immature defense mechanism and 
detoxification pathways (U.S. Surgeon General Report 2007). Besides, children usually 
spend more time outdoors, breath faster, and therefore may receive a greater dose of PM 
than adults. Those children with a history of asthma often exhibit elevated levels of other 
respiratory symptoms such as cough, bronchitis, or pneumonia when living in highly 
polluted areas (California EPA 2005). Passive tobacco smoke exposure can also cause 
different health problems. Specifically, it (1) increases the frequency and severity of 
children’s cold, sore throat, and asthma, (2) aggravates sinusitis, rhinitis, cystic fibrosis, and 
chronic respiratory problems, and (3) causes recurrent ear infections (California EPA 2005).  
In contrast with potentially negative health effects, inhalation therapy for infants and 
children has been employed to deliver pharmaceutical aerosols to the lung via nasal route or 
to the nasal passages as the direct target. Aerosol delivery issues specific to children include 
lower tidal volumes, smaller airway size, and use of mask versus mouthpiece. Only a small 
amount of the applied dose reaches the target receptor in children. Studies have shown that 
for adults about 10% of the administered drug reaches the lung whereas for infants and 
toddlers this percentage is usually less than 1% (Everard 2003). Therefore, children adapted 
methods, dose, and devices are likely to increase therapeutic options leading to improved 
inhalation therapy and medical outcomes. 
A number of in vivo and in vitro studies have considered the deposition of submicrometer 
aerosols in the nasal airway. In vitro studies that evaluated the nasal deposition of ultrafine 
aerosols in humans include Cheng et al. (1996a) and Swift and Strong (1996). The study of 
Cheng et al. (1996a) considered the deposition of aerosols ranging from 4 – 150 nm in 10 
subjects and quantified variability in nasal geometries using MRI scans. Deposition was 
shown to be a function of nasal cavity surface area, minimum cross-sectional area, and 
shape complexity. In vitro studies provide the advantage of avoiding human subject testing 
and can determine depositions within specific regions of the nasal cavity. A number of in 
vitro studies have considered deposition of ultrafine aerosols in replicas of human noses 
(Cheng 2003; Cheng et al., 1993; Cheng et al., 1988; Gradon and Yu 1989; Guilmette et al., 
1994; Kelly et al., 2004b; Yamada et al., 1988). The nasal geometries used in these studies are 
typically derived from medical scan data (CT and MRI) or casts of cadavers. Results of the 
available in vitro experiments are in general agreement with the deposition data from in vivo 
studies for ultrafine aerosols (Cheng et al., 1996a). Based on a collection of in vivo nasal 
deposition studies, Cheng et al. (1996b) suggested a best-fit correlation for particle sizes less 
than 150 nm. Later, Cheng et al. (2003) incorporated in vivo and in vitro nasal deposition data 
of ultrafine and micrometer particles to develop a correlation for particle sizes in the 
diffusional and the impaction deposition regimes. A common disadvantage of both in vivo 
and in vitro methods is the difficulty in determining local deposition values.  
Previous numerical studies have considered the transport and deposition of fine and 
ultrafine particles in the nasal cavity (Liu et al., 2007; Martonen et al., 2003; Schroeter et al., 
2001; Shi et al., 2006; Xi and Longest 2008; Xi and Longest 2009; Yu et al., 1998; Zamankhan 
et al., 2006). Similar CFD studies have also evaluated the transport and absorption of dilute 
chemical species in the nasal passages (Cohen Hubal et al., 1996; Scherer et al., 1994; Zhao et 
al., 2004). Compared with in vitro and in vivo studies, CFD predictions have the advantage of 
providing detailed information on airflow and aerosol deposition, like hot spots that are 
more relevant to health outcome than the average deposition. However, to the authors’ 
knowledge, very few CFD studies have been reported so far studying children nasal 
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depositions, with one exception being Xi et al. (2011) that examined the transport and 
depositions of micrometer particles. The general neglect of child or infant nasal airways in 
previous studies may largely attribute to limited accessibility of pediatric medical images to 
CFD practitioners as well as the complexities involved in constructing physiologically 
realistic nasal passages. Concerning the age-related effect, several investigators have 
evaluated lung depositions of micrometer aerosols using scaled-down tracheobronchial 
models representative of growing lungs at different ages (Asgharian et al., 2004; Crawford 
1982; Oldham et al., 1997; Xu and Yu 1986). In these studies, significant variations in 
micrometer particle lung deposition with respect to age were observed, with higher 
deposition in children than adults. However, no numerical study has considered the age-
related effects upon the nasal deposition of ultrafine and fine-regime aerosols.  
The objective of this chapter is to assess the age effects on airflow and aerosol dynamics 
within the nasal cavity in a systemic manner. There are three specific goals in this study: (1) 
quantifying morphologic dimensions of the nasal airway models for a 9-month-old girl, a 5-
year-old boy, and a 53-year-old adult; (2) numerically characterizing the breathing 
resistance, airflow dynamics, and particle transport within the nasal passages during 
inhalation; and (3) numerically evaluating the deposition of submicrometer aerosols in the 
infant, child, and adult nasal airways on a total, sub-regional, and localized basis. Results of 
this study may lead to a better understanding of the developmental respiratory physiology 
and the associated effects on children’s health response to environmental pollutants, or the 
medical outcome from inhalation therapy for infants and children.  
 
Parameter Range 
dp (nm) Ultrafine: 1, 2, 3, 5, 10, 20, 50, 100 
Fine: 100, 200, 300, 400, 500, 700, 1,000 
Flow rate Qin (L/min) 3, 5, 7.5, 10, 15, 20, 30, 45 
Cunningham correction factor Cc 221 – 1.15 
Particle diffusivity D (cm2/s) 5.44  10-2 – 2.84  10-7 
Schmidt number Sc = /D   2.92 – 5.61  10-5 
Particle Stokes number Stk 2.4  10-8 – 3.0  10-3 
Flow Reynolds number at the inlet 189 – 5,243 
Table 1. Test conditions for the three airway models 
2. Methods 
To achieve the above goals, anatomically realistic nasal airway models have been 
constructed based on CT/MRI images. Breathing scenarios ranging from sedentary through 
heavy activity conditions (i.e., 3–30 L/min) and inhaled particles ranging from 1 nm to 1,000 
nm are considered (Table 1). Details of the geometry construction, inhalation conditions, 
and particle transport models are described below. 
2.1 Construction of the nasal airway models 
For inhalation toxicology and pharmaceutical research, imaged-based modeling represents a 
significant improvement compared with conventional cadaver casting, which is subject to 
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distortion due to the shrinkage of mucous membranes or insertion of casting materials. 
Pritchard and McRobbie (2004) compared a cadaver cast with their MRI oropharyngeal 
airway model averaged over 20 subjects (10 males and 10 females) and showed significant 
geometric disparities. The most prominent difference was the greater volume of the cadaver 
casts, which was 92.7 cm3 for the cast versus 46.7 cm3 (SD12.7) for imaging. Generally, a 
physical model produced from anatomical images results in about 5% difference in the 
airway volume and some loss of fine morphological details. Therefore, this approach may 
adequately approximate the internal geometries (Pritchard and McRobbie 2004). 
 
Fig. 1. Procedures of 3D rendering of CT/MRI images. 
We will use one example to illustrate the computer method for developing a surface model 
of the respiratory tract based on medical images such as CT or MRI data. Figures 1a–e 
illustrate the procedure of translating from CT scans into a high-quality computational mesh 
of the nasal-laryngeal airway (Xi et al. 2010). To construct the 3D airway model, CT scans of 
a healthy non-smoking 53-year-old male (weight 73 kg and height 173 cm) were used, which 
were obtained with a multirow-detector helical CT scanner (GE medical systems, Discovery 
LS) and the following acquisition parameters: 0.7 mm effective slice spacing, 0.65 mm 
overlap, 1.2 mm pitch, and 512512 pixel resolution. The multi-slice CT images were then 
imported into MIMICS (Materialise, Ann Arbor MI) and were segmented according to the 
contrast between osseous structures and intra-airway air to convert the raw image data into 
a set of cross-sectional contours that define the solid geometry (Figs. 1a–c). Based on these 
contours, a surface geometry was constructed in Gambit 2.3 (Ansys, Inc.) (Fig. 1d). The 
surface geometry was then imported into ANSYS ICEM (Ansys, Inc.) as an IGES file for 
meshing. Due to the high complexity of the model geometry, an unstructured tetrahedral 
mesh was created with high-resolution pentahedral elements in the near-wall region (Fig. 
1e). The main geometric features retained in this example include nasal passages, 
nasopharynx (NP), pharynx, and throat. In particular, anatomical details such as uvula, 
epiglottal fold, and laryngeal sinus are retained. The resulting model is intended to 
faithfully represent the anatomy of the extrathoracic airway with only minor surface 
smoothing. Similarly, MRI scans of a healthy 5-year-old boy (weight 21 kg and height 109 
cm) and CT scans of a 9-month-old girl (weight and height unknown) were used in this 
study to construct the pediatric nasal airway models. In order to quantitatively evaluate the 
flow field and aerosol depositions within the nasal airway, the airway model is divided into 
different sections (Fig. 2). In the main flow direction, subregions include the nasal vestibule 
and valve region (V&V), turbinate region (TR), nasopharynx (NP), pharynx and larynx. On 
top of the nasal airway is the olfactory region (OR) where the sensory nerves are located. 
(c) Defining Polylines (a) MRI/CT (b) Solid Body (d) Surface Model (e) Mesh 
MIMICS IGES Gambit 
ICEM 
www.intechopen.com
Ultrafine and Fine Aerosol Deposition  
in the Nasal Airways of a 9-Month-Old Girl, a 5-Year-Old Boy and a 53-Year-Old Male 
 
51 
 
Fig. 2. Image-based nasal-laryngeal airway models.  
2.2 Boundary conditions 
Steady inhalation was assumed for all simulations with uniform velocity profiles at both nose 
inlets (nostrils) (Fig. 2). Initial particle velocities were assumed to be the same as the local fluid 
velocity. The airway surface was assumed to be smooth and rigid with no-slip (uwall = 0) and 
perfect absorption conditions. In the body, the extrathoracic airway is covered with a thin layer 
of mucus, which captures particles at initial contact and clears them to the throat or nasal 
vestibule by mucocilliary movement within a time period of 10 to 15 minutes. Mass diffusion 
and metabolism of deposited particles may occur within the mucus layer and may change the 
zero-concentration conditions at the wall. However, due to the slow speed of the mucocilliary 
movement compared with the intranasal airflow and relatively low deposition rates, the no-
slip and perfect absorption conditions are reasonable approximations in this study. 
2.3 Fluid and particle dynamics equations 
Flows in this study are assumed to be isothermal and incompressible. The mean inlet 
Reynolds number at the trachea varies from 368 to 3,302. The maximum Reynolds number 
based on the hydraulic diameter of the glottal aperture is approximately 8,037. Multi-regime 
flow dynamics can coexist in the nasal airway due to its unique physiology. To resolve the 
possible laminar-transitional-turbulent flow conditions, the low Reynolds number (LRN) k-
 model was selected based on its ability to accurately predict pressure drop, velocity 
profiles, and shear stress for transitional and turbulent flows. Moreover, the LRN k-ω model 
was shown to provide an accurate solution for laminar flow as the turbulent viscosity 
approaches zero (Wilcox 1998). 
The transport and deposition of the submicrometer particles are simulated with a  
well-tested discrete Lagrangian tracking model enhanced with near-wall treatment. The 
aerosols evaluated in this study had a density of 1.0 g/cm3 and particle Stokes number  
(Stk = pdp2U/18μDh) range of 0.00001 to 1.0. The inhaled particles were assumed to be dilute 
and had no influence upon the continuous-phase, i.e., one-way coupled particle motion. In 
our previous studies, the Lagrangian tracking model enhanced with user-defined routines 
was shown to provide close agreement with experimental deposition data in upper 
respiratory airways for both submicrometer (Xi et al., 2008) and micrometer particles (Xi and 
Longest 2007). The discrete Lagrangian transport equations can be expressed as 
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i
dx
v t
dt
  (1) 
where vi and ui are the components of the particle and local fluid velocity, and p (i.e., p 
dp2/18) is the characteristic time required for a particle to respond to changes in the flow 
field. The drag factor f, which represents the ratio of the drag coefficient CD to Stokes drag, is 
based on the expression of Morsi and Alexander (1972). The influence of non-uniform 
fluctuations in the near-wall region is taken into account by implementing an anisotropic 
turbulence model proposed by Matida et al. (2004), which is described as 
 ' 2 / 3 1 exp( 0.002 )n v vu f k and f y      (2) 
In this equation, ξ is a random number generated from a Gaussian probability density 
function and fv is a damping function component normal to the wall for values of y+ less 
than 40. Away from the wall (y+ > 40), fv = 1. 
Evaluation of the particle trajectory equation requires that the fluid velocity ui be 
determined at the particle location for each time-step. On a computational grid, determining 
the fluid velocity at the particle location requires spatial interpolation from control-volume 
centers or nodal values. Based on studies of deposition in the oral airway using Fluent 6, 
fluid velocities in wall-adjacent control volumes were observed to maintain the value at the 
control-volume center and not approach zero at the wall (Longest and Xi 2007). Longest and 
Xi (2007) reported that a near-wall interpolation (NWI) algorithm provided an effective 
approach to accurately predict the deposition of nanoparticles in the respiratory tract. A 
user-defined routine was developed that linearly interpolates the fluid velocity in near-wall 
control-volumes from nodal values. Velocity values at the wall were taken to be zero. 
2.4 Numerical method and convergence sensitivity analysis 
To solve the governing mass and momentum conservation equations in each of the cases 
considered, the CFD package ANSYS Fluent 6.3 was employed. User-supplied Fortran and 
C programs were implemented for the calculations of inlet flow and particle profiles, 
particle transport and deposition locations, grid convergence, and deposition enhancement 
factors. A specific set of user-defined functions was also applied for implementing the 
anisotropic turbulence effect and near-wall velocity interpolation. All transport equations 
were discretized to be at least second order accurate in space. A segregated implicit solver 
was employed to evaluate the resulting linear system of equations. This solver uses the 
Gauss-Seidel method in conjunction with an algebraic multigrid approach for improving the 
calculation performance on tetrahedral meshes. Convergence of the flow field solution was 
assumed when the global mass residual was reduced from its original value by five orders 
of magnitude and when the residual-reduction-rates for both mass and momentum were 
sufficiently small.  
The computational meshes of the four nasal-laryngeal airway models were generated with 
ANSYS ICEM 12.0 (Ansys, Inc.). An unstructured tetrahedral mesh was generated with 
high-resolution prismatic cells in the near-wall region (Fig. 3) to accommodate the high 
complexity of the model geometry. A grid sensitivity analysis was conducted by testing the 
effects of different mesh densities with approximately 540,200, 980,900, 1,750,000 and 
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2,812,000 control volumes while keeping the near-wall cell height constant at 0.05 mm (Xi et 
al., 2008). Increasing grid resolution from 1,750,000 to 2,812,000 control volumes resulted in 
total deposition changes of less than 1%. As a result, the final grid for reporting flow field 
and deposition conditions consisted of approximately 1,750,000 cells with a thin five-layer 
pentahedral grid in the near-wall region and a first near-wall cell height of 0.05 mm. 
 
Fig. 3. Coronal view of the ICEM-generated computational mesh of the 53-year-old male. 
For discrete Lagrangian tracking, the number of seeded particles required to produce count-
independent depositions was tested. Particle count sensitivity analysis was performed by 
incrementally releasing groups of 10,000 particles. The number of groups was increased 
until the deposition rate changed by < 1%. The final number of particles tracked for ultrafine 
and fine-regime aerosols were 60,000 and 100,000 respectively. 
3. Results 
3.1 Infant-child-adult discrepancy 
The differences of nasal airways among a 9-month-old girl, a 5-year-old boy (Xi et al., 2011) 
and a 53-year-old male reported previously (Xi and Longest 2008) are quite obvious in both 
morphology and dimensions. As for the morphology, younger subjects have smaller sized 
nostrils, shorter turbinate regions, longer but thinner nasopharynx, and thinner pharynx-
larynx. It is therefore expected that as a human grows from birth to adulthood, the airway 
geometry keeps changing, which in turn alters the nasal aerodynamics as well as the 
deposition patterns of inhaled aerosols.  
A quantitative comparison of airway dimensions among these three subjects is shown in 
Fig. 4 in terms of coronal cross-sectional area and hydraulic diameter dh, both as a function 
of distance from the nose tip. Comparison of airway volume and surface area among the 
three subjects for various nasal anatomical sections are listed in Table 2. The dimension of 
two nostrils and upper trachea are shown in Table 3. It is noted that the test conditions (such 
as geographical elevation) are not clear for these three subjects, and the differences  
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Anatomical 
sections* 
Volume,  
V (cm3) 
Surface area, 
A (cm2) 
Effective diameter,  
de‡ (cm) 
9-m 5-yr Adult 9-m 5-yr Adult 9-m 5-yr Adult 
V&V 1.25 3.37 5.50 9.75 23.74 35.58 0.512 0.568 0.619 
TR 2.83 11.03 12.63 35.63 107.34 112.59 0.318 0.411 0.449 
NP 1.74 3.95 16.33 9.27 15.27 40.93 0.750 1.034 1.595 
Pharynx 3.19 2.64 13.89 13.71 14.59 45.10 0.932 0.724 1.232 
Larynx 1.32 1.22 6.70 8.37 7.20 21.81 0.629 0.676 1.228 
Total 10.33 22.21 55.05 76.73 168.14 256.01 0.538 0.528 0.860 
* V&V (vestibule and valve region), TR (turbinate region), NP (nasopharynx) 
‡ Effective diameter de = 4V/A 
Table 2. Comparison of nasal airway dimension among an infant, a child and an adult. 
 
Anatomical 
sections 
Cross-sect area,  
A (mm2) 
Perimeter,  
P (mm) 
Hydr. diameter,  
dh‡ (mm) 
9-m 5-yr Adult 9-m 5-yr Adult 9-m 5-yr Adult 
R nostril 27.98 49.20 101.27 19.92 25.61 44.53 5.62 7.68 9.10 
L nostril 31.48 43.74 101.27 20.49 24.89 44.53 6.15 7.03 9.10 
Trachea 50.64 83.23 148.66 25.59 33.59 45.66 8.01 9.91 13.02 
‡ Hydraulic diameter dh = 4A/P 
Table 3. Dimension of the nostrils and upper trachea of the three airway models. 
presented herein are assumed to be mainly attributed to the age effect. From Table 2, the 
nasal airway volume of the 9-month-old infant and the 5-year-old child is 18.8% and 40.3% 
that of the adult, respectively; while the nasal airway surface area of the infant and child is 
30.0% and 65.7% that of the adult, respectively. In particular, two major disparities are 
noted. First, the infant and child both possess a much narrower and smaller nasopharynx 
lumen compared to that of the adult. From Fig. 4a, the NP cross-sectional area of the infant 
(i.e., A = 78 mm2) and child (i.e., A = 170 mm2) is only one seventh and one third that of the 
adult (i.e., A = 535 mm2) respectively. From Fig. 4c, the NP hydraulic diameter of the infant 
(i.e., 8.1 mm) and the child (i.e., dh = 12.2 mm) is about one third and half that of the adult 
(i.e., dh = 24.0 mm), respectively. Secondly, the distance to the nasal valve (the minimum 
cross-sectional area) is much shorter for the 9-month infant (11.2 mm, blue solid arrow in 
Fig. 4a) compared to the 5-year-old child (20.8 mm, black arrow) and adult (27.2 mm, red 
arrow). Similarly, the nasal valve area is also much smaller for the infant (i.e., ~56 mm2) 
compared to both the child and adult, while the later two subjects have similar valve areas 
(i.e., ~180 mm2) (Fig. 4a). This observation may imply that the nasal valve matures at early 
ages (around 5 years old). Another similar observation is for the nasal turbinate region, 
where the hydraulic diameter of the child and adult are very close (~10.0 mm) while that of 
the infant is much smaller (~3.8 mm).  
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Fig. 4. Comparison of nasal cross-sectional area, perimeter, and hydraulic diameter between 
a 9-month-old girl, a five-year-old boy, and an adult male. 
 
Fig. 5. Pressure drop (i.e., breathing impedance) as a function of inhalation flow rate with 
comparison to in vitro and in vivo measurements in various age groups. 
3.2 Breathing resistance 
Figure 5 shows the predicted breathing resistance (∆p) within the infant, child, and adult 
nasal airways considered in this study in comparison with existing in vitro and in vivo 
measurements for various age groups. In vitro data presented include an infant (9 month) 
(Janssens et al., 2001), young children (1.5 yr, 2.5 yr, 4 yr) (Cheng et al., 1995c), and adults 
(Kelly et al., 2004a; Yamada et al., 1988). In vivo data are from adult subjects (34 ± 5 yr) 
before and after exercise (Wheatley et al., 1991). In general, the pressure drop (i.e., breathing 
impedance) decreases as the age increases. Infants and children have much higher breathing 
impedance than adults for a same flow rate. As expected, the pressure drop curve of the 9-
month infant agrees fairly well with the 9-month in vitro measurements (Janssens et al., 
2001), and that of the 5-year-old boy falls between those of young children and adults. 
Children grow fast in height and weight before the age of seven and the rate of growth 
decreases thereafter, so does the growth of nasal airway. It is therefore reasonable that the 
infant breathing resistance is much higher while the 5-year-old breathing resistance is 
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somewhat between infants and adults. The pressure-flow relationships can be expressed as 
a power function (ΔP = a·Qb), which can be plotted as straight lines on a log-log scale with 
slope “b”. Table 4 lists the coefficients “a” and “b” for subjects of different ages. In light of 
the age-related effects, “a” constantly decreases in magnitude as age increases (from 8.87 at 9 
month old to 0.54–0.16 when grown up) whereas the slopes of the ∆p-Qin curve are similar 
for all ages (b = 1.71–1.98).  
 
Age/Reference Method a* b* 
9 m (Saint), Janssens (01) in vitro, CT cast 8.87 1.75 
9 m, This study CFD, CT model 4.01 1.84 
1.5 yr, Cheng (95) in vitro, MRI cast 5.24±0.70 1.98±0.060 
2.5 yr, Cheng (95) in vitro, MRI cast 4.46±0.15 1.87±0.014 
4 yr, Cheng (95) in vitro, MRI cast 3.40±0.20 1.86±0.023 
5 yr, This study CFD, MRI model 1.07 1.89 
Adult, Yamada (88) in vitro, Cadaver cast 0.54 1.85 
34 ± 5 yr, Wheatley (95) in vivo, Pre-exercise 0.43±0.34 1.75±0.030 
34 ± 5 yr, Wheatley (95) in vivo, Post-exercise 0.20±0.35 1.90±0.028 
53 yr, This study CFD, MRI model 0.31 1.84 
53 yr, Kelly (04) in vitro, MRI cast, (nose only) 0.16 1.71 
 *    / min bP Pa aQ L   
Table 4. Pressure drop (i.e., breathing impedance) in nasal airways at different ages,  
3.3 Airflow field and particle transport 
Comparison of airflow fields in the infant, child, and adult nasal airways are shown in Fig. 6 
for an inhalation flow rate of 20 L/min. It is noted that this flow rate represents quite 
different physical activity conditions for the three subjects, i.e., light activity for the adult, 
medium activity for the child, and heavy activity for the infant. It is also noted that different 
velocity scale is used in each model. From Fig. 6, flows of high velocity magnitude are 
observed in the middle portion of the nasal passage for all the three models considered. In 
contrast, the narrow fin-like meatus regions receive a minimal fraction of the airflow, 
especially in the deeper portions of each meatus. The main flow changes its direction 
dramatically from the nostrils to the nasopharynx, forming a nearly 180o curvature; 
however, this curvature is less severe for the infant model compared to the other two, 
preassembly resulting from a more back-tilted head position of the infant during image 
acquiring. No recirculation zone is observed in the infant and child NP due to a much 
smaller airway diameter in this region, which is different from the adult NP where flow 
recirculation is obvious (Xi and Longest 2008). 
To compare secondary velocity motions of the three models considered, two-dimensional 
stream traces are plotted in the anterior and posterior passages of each model (Slices 2-2’ 
and 3-3’). Due to the thin air channels, vortices are damped and not discernable in the nasal 
passage. The magnitude of the secondary velocity in each slice is approximately 10% - 30% 
of the main flow. It is interesting to note that the relative strength of the second motion  
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Fig. 6. Velocity fields in the nasal passages of the infant, child, and adult at 20L/min. 
varies among the three age groups, which progressively increases as age increases. Take the 
middle passage (Slice 2-2’) as an example. The ratio of the secondary velocity to the mean 
speed is 3.6 to 25% with a median of 16% for the 9-month infant, 9.8 - 36% with a median of 
25% for the 5-year-old child, and 13 to 40% with a median of 29% for the adult. The 
secondary motion functions to distribute the inhaled air into each fin-like meatus. Therefore, 
this difference might reflect the more matured (and more complicated) nasal turbinate at 
elder ages that more effectively convey the airflow throughout the nasal passages. Of 
particular interest is the observation of transportation of airflow toward the olfactory region. 
The secondary flows move upward prior to the olfactory region (Slice 2-2’) and downward 
after the olfactory region (Slice 3-3’). It is expected that the secondary motion near the 
olfactory region is delicately balanced, which should be large enough to convey a sufficient 
amount of particles or vapors for the olfactory nerve to perceive while still remaining small 
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enough to protect this extremely sensitive area that is directly connected to the brain. It is 
also interesting to note that the right and left nasal passages are quite different both in 
geometry and flow fields for all the three models considered, with one passage being more 
constricted than the other (Fig. 6). This geometric disparity is possibly attributed to the 
natural nasal cycle during which the airway obstruction alternates over a period of several 
hours (Eccles 1996). The resulting difference in airflows between the right and left passages 
has been suggested to help the central nerve system to locate where smell comes from.  
 
Fig. 7. Snapshots of particle locations through the right nasal passage of (a) 9-month-old girl, 
(b) 5-year-old boy, and (c) 53-year-old male. For each model, an amount of 2,000 particles of 
500 nm were released at the right nostril at t = 0 ms and recorded at various instants. 
Particle transport within the right nasal passage of the three models considered are visualized 
in Fig. 7 as snapshots of particle locations at specified instants for an inhalation flow rate of 20 
L/min. Two thousand 500 nm particles were released at the right nostril at t = 0 ms and 
particle positions were recorded after designated period of times. Due to the small inertia and 
diffusion of the aerosols considered, particles are assumed to closely follow the airflow. For all 
the three models, faster transport and deeper penetration of aerosols are apparent in the 
medial passages while slow-moving particles are found near the airway walls. Because of the 
dramatic airway bend from the nostril to the nasopharynx, a high-concentration of particles 
constantly adjusts their directions following the mean streamline curvature of inhaled 
airflows. Considering that 20 L/min represents different levels of physical activity for the three 
subjects considered, the time required for the aerosols to fill the nasal airway also varies. It 
takes about 20 ms for particles to first reach the upper trachea for the infant (green symbols), 
whereas it takes 60 ms for the child, and 100 ms for the adult. The seemingly random particle 
distributions downstream of the nasopharynx indicate enhanced turbulent mixing in those 
regions. Due to the small-sized nasopharynx-larynx in both the infant and child, particles in 
this region are transported at a much higher rate than in adult (i.e., from NP to larynx taking 
10 ms for the infant, 20 ms for the child, vs. 40 ms for the adult). 
3.4 Particle deposition 
Comparison of surface depositions in the infant, child, and adult nasal airways are shown in 
Fig. 8 for aerosols within both ultrafine (1–10 nm) and fine (100–1,000 nm) regimes at a 
constant inhalation flow rate of 20 L/min. Overall, much similarity than difference was 
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observed in the three models considered, whose deposition patterns exhibit much less 
heterogeneity than that we observed for micron particles (Xi et al., 2011). As expected, a 
large amount of ultrafine aerosols deposit in the nasal airways for all the models considered, 
while only a small amount of fine-regime aerosols deposit. In light of local depositions, 
ultrafine aerosols accumulate either in turbinate region or pharynx-larynx region, while the 
fine-regime aerosols accumulate mainly in the pharynx-larynx region where turbulence is 
most pronounced. One explanation for the ultrafine particle accumulation in the turbinate 
region is the narrow airway channel with the high particle diffusivity that disperses 
ultrafine particles onto the turbinate walls.  
 
Fig. 8. Surface deposition in the three models of particles of (a) ultrafine regime (1 nm to 10 
nm only) and (b) fine regime (100 nm to 1,000 nm). The fine-regime depositions are shown 
with 50% translucence. 
Figure 9 shows the 3-D surface plot of the deposition fractions in the infant, child, and adult 
nasal airways as a function of both inhalation flow rate and particle size. The inhalation flow 
rates considered are 3, 5, 7.5, 10, 15, 20, 30, 45 L/min and the particle sizes are in the range of 
1–1,000 nm. The three surface plots look alike both in trend and magnitude, with declining 
deposition rate as the particle size and flow speed increase. The peak deposition rate occurs 
at the smallest particle size and lowest flow rate considered (dp = 1 nm and Qin = 3 L/min) 
where the Brownian motion and residence time of the particles are both maximal. However, 
the relative role of the convective (flow rate) and molecular (particle size) diffusion differs in 
the ultrafine aerosol deposition, as the effect of molecular diffusion apparently overweighs 
that of convection for the breathing conditions considered herein. Considering the fine 
regime particles in the range of 100–1,000 nm, very low deposition fractions are observed for 
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all models considered. However, further examination of Fig. 9 reveals an interesting 
phenomenon associated with the interactions between mechanisms of diffusion and inertial 
impaction. For all three models considered, the deposition rate decreases first and then 
starts to increase with increasing particle size and flow rate. This valley-shaped profile 
results from a competition between the diminishing diffusive effect and enlarging finite 
inertial effect as the particle size and flow rate continuously rise, with the minimum 
occurring when the sum of these two effects is the smallest. But the breathing scenario of 
minimal deposition varies for the three age groups, which is at the inhalation flow rate of ~3 
L/min for the infant and child, and is ~10 L/min for the adult, as shown in Fig. 9. 
 
Fig. 9. 3-D surface plot of the total deposition fractions as a function of particle diameter and 
inhalation flow rate in the nasal-laryngeal airway models of (a) 9-month-old girl, (b) 5-year-
old boy, and (c) 53-year-old male. 
To further evaluate the predicted deposition results, the same data set from Fig. 9 has been 
plotted as a function of two existing diffusion parameters proposed from in vitro and in vivo 
deposition studies (Fig. 10). The first parameter (D0.5Q-0.125) was theoretically derived by 
Cheng et al. (1988) based on the assumption of turbulent diffusion in pipe flow and was 
later adopted in a series of in vitro replica studies (Cheng et al., 1995b; Cheng et al., 1993; 
Cheng et al., 1996b). The second parameter (D0.5Q-0.28) was later derived by Cheng et al. 
(2003) based on in vivo nasal deposition data, which exhibited a greater dependence on flow 
rate (i.e., exponent of -0.28) than the replica-based parameter (i.e., exponent of -0.125). 
Figures 10a and 10b shows the comparison of deposition profiles for the 53-year-old adult 
plotted as a function of the above two diffusion parameters. It is noted from Fig. 10a that the 
deposition results do not fully collapse for different flow rates and particle sizes, suggesting 
that the replica-based parameter (D0.5Q-0.125) does not accurately account for the relative  
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Fig. 10. Comparison of the deposition fractions as a function of the diffusion factor based on 
existing (a) in vitro (D0.5Q-0.125) and (b) in vivo (D0.5Q-0.28) studies in the male adult model. 
Inclusion of the Cunningham correction factor (Cc) improves agreement between the 
correlation and numerical data (b). The deposition fractions and associated correlations for 
(c) 9-month-old girl and (d) 5-year-old boy are also shown as a function of (D0.5Q-0.28). Units: 
Q [L/min] and D [cm2/s]. 
effect from convection and diffusion. In contrast, a more precise correlation was obtained by 
plotting the results as a function of the in-vivo-based parameter (D0.5Q-0.28). Following the 
format of the in vivo empirical correlation suggested by Cheng et al. (2003), DF = 1 - exp(-a 
D0.5Q-0.28), a coefficient of a = 12.5 was obtained for the 53-year-old deposition results (Fig. 
10b). The resulting R2 value was 0.92, indicating reasonably good agreement between the 
numerical data and the proposed empirical correlation. However, deviations becomes 
noticeable from D0.5Q-0.28 = 0.11 and aggravates thereafter. Considering that deposition in 
the diffusion regime was also affected by non-continuum effects, the Cunningham 
correction factor Cc was incorporated into the diffusion parameter as (CcbD0.5Q-0.28) (Xi and 
Longest 2009). Again, an equation of DF = 1 - exp(-c CcbD0.5Q-0.28) was used to fit the 
expiratory simulation data. The best-fit values of b and c were 0.25 and 3.5, respectively, 
resulting in R2 = 0.98 (Fig. 10b). The resulting ultrafine regime correlation in the nasal-
laryngeal airways for adult is expressed as 
 Adult: 0.25 0.5 0.281 exp( 3.5 )cDF C D Q
    (3) 
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As evident from Fig. 10a and b, inclusion of the Cunningham correction factor results in a 
better approximation of the numerical data in comparison to the in-vivo-based correlation 
(Fig. 10b), and represents a significant improvement over the replica-based profile in Fig. 
10a. 
Figures 10c and 10d show the predicted deposition results as a function of D0.5Q-0.28 for the 9-
month infant and 5-year-old child, respectively. The adult deposition data are also 
superimposed in these two plots to emphasize the age-related effects. Likewise, better 
approximations are obtained by including the Cunningham factor for the deposition results 
of the infant and child, which for the infant is expressed as 
 9-month-old infant: 0.17 0.5 0.281 exp( 3.9 )cDF C D Q
    (4) 
For a given value of diffusion factor (D0.5Q-0.28), the deposition results of the infant falls 
below those of the child and adult, while results of the child and adult appear to collapse 
into a single curve. As such, the correlation (Eq. 3) is also applied to the 5-year-old child 
model in this study.  
3.5 Sub-regional and local depositions 
Sub-regional deposition fractions within specific sections of the nasal airway are illustrated 
in Figs. 11-13. The sub-regions considered include nasal vestibule and valve (V&V), 
turbinate region (TR), nasopharynx (NP), pharynx, and larynx, as illustrated in Fig. 2. Figure 
11 shows the surface plot of the sub-regional deposition fractions as a function of particle 
diameter and inhalation flow rate in the 9-month infant model. Surface plots in the child and 
adult models appear similar and are not shown. Unlike the total deposition plot in Fig. 9a, 
the flow-deposition response is noted to vary at each sub-region. In the nasopharynx (NP), 
the deposition fractions appear independent of the flow rate and being a function of particle 
diameter only (Fig. 11a). Furthermore, in the pharynx region, reduced ultrafine depositions 
are observed for smaller flow rates, which is opposite to the total deposition plot (Fig. 11 d 
vs. Fig. 9). This seemingly contrary observation is partially due to the fact that at low flow 
rates the majority of ultrafine particles entering the nose have deposit in the vestibule and 
turbinate regions already, leaving only a small amount of particles to deposit in the 
downstream regions. This depleting mechanism of particles into the anterior nasal passages 
is more pronounced at even lower inhalation flow rates.  
Comparison of sub-regional deposition among the infant, child, and adult models is shown 
in Fig. 12 for varying particle sizes and in Fig. 13 for varying flow rates. For a same flow rate 
(15 L/min in Fig. 12), deposition rate consistently decreases with enlarging particles in each 
sub-region considered. However, this consistency is missing as to the flow rate effect upon 
the sub-regional deposition for an identical particle size (Fig. 13). Many factors could 
contribute to the erratic flow-deposition relations in Fig. 13 such as turbulence intensity, 
secondary motion, particle depletion in upstream regions, etc. In light of age effects, one 
observation is noteworthy: the deposition partition among the four sub-regions (i.e., 
turbinate, nasopharynx, pharynx, and larynx) is different for the three airway models. For 
example, in the turbinate region, the 5-year-old child model receives the highest deposition 
while the adult model receives the least for all particle sizes and flow rates considered (Figs. 
12a, 13a). While in the larynx, the 5-year-old model receives less than the other two models.  
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Fig. 11. 3-D surface plot of the sub-regional deposition fractions as a function of particle 
diameter and inhalation flow rate in the 9-month girl model at the site of (a) nasal vestibule 
and valve region, (b) turbinate region, (c) nasopharynx, (d) pharynx, and (e) larynx. 
Mechanisms behind these irregular partitions could be complex. For example, the 
nasopharynx in adult has a much larger size and receives a twice larger deposition than in 
the infant and child. In contrast, the pharynx in child is smallest in size while receives the 
highest deposition among the three. This finding is worthy of our further attention. For 
inhalation toxicology, it means a different burden on the region of interest among different 
age groups. Meanwhile, for inhalation therapy that targets drugs at designated site of the 
respiratory system, this finding implies that existing adult deposition results might not 
guarantee an accurate dose planning for children and infants.  
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Fig. 12. Comparison of sub-regional deposition fractions between the three models (9-
month, 5-year, 53-year) for different particle sizes (5 nm, 50 nm, and 500nm) at the site of (a) 
turbinate region, (b) nasopharynx, (c) pharynx, and (d) larynx. 
To highlight the age-related effects on microdosimetry, a comparison of deposition 
enhancement factor (DEF) values among the infant, child, and adult models is illustrated in 
Fig. 14 for particles of 5 nm and an inhalation flow rate of 20 L/min. As discussed, the DEF 
value quantifies the particle dosage over an area of 50 airway epithelial cells in length with 
respect to the average deposition rate. The maximum DEF values are of the same order of 
magnitude for the three subjects considered, i.e. 26 – 41, with the youngest subject having 
the highest DEF value. This is in contrast with the highly concentrated accumulations of 
micron aerosols observed in the 5-year-old child model (Xi et al., 2011), which is one order 
of magnitude higher (i.e., DEFmax = 830 for 10 μm particles and 10 L/min flow rate ). The 
overall pattern of deposition enhancement appears very similar for these three models. Each 
model exhibits hot spots on the dorsal walls of the larynx where convective diffusion is high 
due to converging airflow to the narrow glottis. Other hot spots with less elevated DEF 
values are observed for each model in the turbinate region. It is also noted that the nasal 
valve and pharyngeal dorsal wall do not have significant hot spots, which was the case for 
10 μm aerosols (Xi et al., 2011). This lack of hot spots in the valve and pharynx regions is due 
to the negligible inertial impaction effect for ultrafine particles which can closely follow the 
main flow and easily maneuver through the constricted or highly curved passages.  
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Fig. 13. Comparison of sub-regional deposition fractions between the three models (9-
month, 5-year, 53-year) for different inhalation flow rates (7.5 L/min, 15 L/min, and 30 
L/min) at the site of (a) turbinate region, (b) nasopharynx, (c) pharynx, and (d) larynx. 
Local depositions for nanoparticles of sizes other than 5 nm and for different breathing 
conditions have been studied but not shown. Generally, it is found that for larger 
nanoparticles, existing hot spots shrink in size and become more concentrated due to rising 
particle inertia while deposition in other areas becomes more uniform due to decreased 
particle diffusivities. For 100 nm aerosols, hot spots reduce to regions only surrounding the 
glottis. Further, particles are more evenly distributed for heavier activity conditions.  
4. Discussion 
Significant differences were noted of the nasal anatomy among the infant, child, and adult 
subjects considered. These differences manifest themselves not only in airway dimension 
but also in airway morphology. For example, the nasal airway volume of the 9-month-old 
infant and the 5-year-old child is 18.8% and 40.3% that of the adult, respectively. At the 
same time, the infant and child have smaller sized nostrils, a shorter turbinate region, and a 
much slender nasopharynx. Results of this study indicate that the nasal valve and vestibule 
region might mature around the age of five. This is supported by the much shorter nostril-
valve distance (i.e., 11.2 mm for infant vs. 20.8 mm for child and 27.2 mm for adult) and  
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Fig. 14. Comparison of deposition enhancement factors (DEF) at Qin = 20 L/min and dp = 5 
nm in (a) 9-month-old girl, (b) 5-year-old boy, and (c) 53-year-old male. 
much smaller valve cross-sectional area (i.e., 56 mm2 for infant vs. ~180 mm2 for child and 
adult) of the 9-month infant compared to the 5-year-old child and adult (Fig. 4). The 
turbinate region experiences fast growth from birth to the age of five as indicated by the 
remarkable volume increase of this region in Table 2 (i.e., 2.83 cm3 for infant, 11.03 cm3 for 
child, and 12.63 cm3 for adult); however, a lack of similarity in shape between the child and 
adult may still mean an undeveloped turbinate. It is apparent that the nasopharynx grows 
the least during the first five years (i.e., volume = 1.74 cm3 for infant, 3.95 cm3 for child, and 
16.33 cm3 for adult, Table 2). These child-adult discrepancies necessitate studies of specific 
age groups, or of the associated age effects.  
Respiratory disorders are diverse in etiology and manifestations. Knowing detailed 
deposition information will greatly facilitate causality identification and dose-response 
assessment. The sub-regional and localized deposition values herein, which are amongst the 
first studies characterizing the detailed depositions in infants and children, have 
implications in narrowing down or pinpointing the site of highest possibility site (SHP) for 
respiratory lesions. These deposition hot spots are most susceptible to cancer formation, and 
are therefore extremely important to identify. For instance, a recent report by the National 
Research Council (NRC 2008) indicates that the in vivo response to inhaled bioaerosols is 
largely dependent on the site of local particle deposition within the respiratory tract. In this 
study, the deposition hot spots occur mainly on the turbinate and the dorsal wall of the 
larynx. Besides, the deposition partition in sub-regions (i.e., turbinate, nasopharynx, 
pharynx, and larynx) is quite different among the three age groups, indicating a different 
level of burdens upon the region of interest even when exposed to the same environment. 
From the drug delivery perspective, this difference finding implies that existing adult 
deposition results might not guarantee an accurate dose planning for children and infants.  
While multiple empirical correlations of nasal nanoparticle depositions exist for adult and to 
a lesser extent for children, correlations including the age-related effects have rarely been 
reported. A significant issue in accounting for age effects is to determine the appropriate 
parameter that best represents the variations of nasal morphology and dimension with age. 
This parameter could be biological data such as age, height, weight, head circumference, or 
nasal airway data itself such as volume, surface area, hydraulic diameter, or even a 
combination of the two. Even though a single correlation applicable to all age groups is 
highly desirable, such a correlation has to be awaited until more nasal morphology and 
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deposition data become available for subjects of a large spectrum of ages. It is also a 
reminder (or caution) that there exist multiple ways in presenting/comparing/extrapolating 
deposition data in light of the age effects. For instance, besides the ventilation rate as in this 
study, deposition rates have also been compared in terms of physical activity level 
(Becquemin et al., 1991), per airway surface area (Diot et al., 1997), and per body mass 
(Phalen et al., 1991) depending on their comparison purpose. Considering the fact that 
terminologies defining the ventilation level are relatively arbitrary as no standard 
definitions exist (Phalen et al., 1985), comparing data from different studies is often not 
straightforward.   
Limitations of this study include the assumptions of steady flow, simplified inlet conditions, 
ridge airway walls, and non-varying valve and glottal aperture. Other studies have 
highlighted the physical significance of transient breathing (Shi et al., 2006), inlet velocity 
profiles (Keyhani et al., 1995; Subramaniam et al., 1998), nasal wall motion (Fodil et al., 
2005), nasal valve change (Bridger 1970; Bridger and Proctor 1970) and glottal aperture 
variation (Brancatisano et al., 1983; Xi et al., 2008). Moreover, each nasal model in this study 
is based on images of one single subject and does not account for the intersubject variability 
(Hilberg et al., 1993; Pickering and Beardsmore 1999). Another limitation is the typical 
supine position of the subjects during data acquisition, which is different from normal 
breathing while awake. Images are also taken at the end of the inhalation which may not 
reflect variations in airway geometry during a full breathing cycle. Therefore, future studies 
are needed that should be orientated toward: (1) improving physical realism and (2) 
including a broader population group. Our knowledge of nasal deposition is currently 
lacking in subpopulations such as pediatrics, geriatrics, and patients with respiratory 
diseases. Due to physiological development, aging, or diseases states, the airway anatomy can 
be remarkably different from that of a healthy adult. Concentrating on these specific 
subpopulations will help to clarify inter-group and inter-individual variability and will allow 
for the design of more efficient pharmaceutical formulations and drug delivery protocols. In 
particular, future in vivo and in vitro studies are needed to cross-validate numerical predictions 
before such results as in this study can be applied to clinical applications.   
5. Conclusion 
In conclusion, this study has assessed the age-related effects on airflows, breathing 
impedance, and submicrometer particle depositions in the nasal airways of a 9-month girl, a 
5-year-old boy, and a 53-year-old male. A wide spectrum of breathing conditions (3–45 
L/min) and aerosol sizes (1–1,000 nm) have been studied by means of numerical 
simulations. Specific findings of this study include: 
1. Significant infant-child-adult discrepancies exist in the nasal airways in both 
morphology and dimension. Overall, the younger subject has smaller nostrils, a shorter 
turbinate region, and a slender nasopharynx. Besides, the 9-month infant has much 
shorter nostril-valve distance and much smaller valve cross-sectional area relative to the 
5-year-old child and adult, while those of the later two subjects are similar in size, 
indicating a maturing of nasal valve at early ages (~ 5 years old). The nasal airway 
volume of the infant and child is 18.8% and 40.3% that of the adult, respectively; while 
the nasal airway surface area of the infant and child is 30.0% and 65.7% that of the 
adult, respectively.  
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2. Airflow in the main nasal passages was mostly laminar and transitional for all models 
considered at an inhalation flow rate of 20 L/min, with turbulence occurring mainly in 
the pharynx and larynx regions.  
3. For a same flow rate, breathing resistance persistently decreases with rising age for the 
three models in this study. An empirical correlation for the breathing resistance was 
developed for different age groups based on a wide range of test conditions. 
4. Insignificant variations in total and local depositions were found among the three 
models, even though discernible differences can still be noted for hot spot locations and 
intensities. However, the deposition partitioning in the sub-regions (i.e., turbinate, 
nasopharynx, pharynx, and larynx) was quite different among the three models 
considered.  
5. Improved correlations of nasal deposition for ultrafine aerosols were developed for 
different age groups by implementing an in vivo-based diffusion parameter and the 
Cunningham correction factor. These correlations can also be applied to depositions of 
gases and vapors in the nasal airway for cases of rapid absorption on the airway 
surface. 
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